In a personal health column for The New York Times, Jane Brody discusses the state-by-state study on disease produced by IHME and interviews IHME Director Christopher J.L. Murray.
The Dog Aging Project is looking at a drug known as rapamycin, which is already approved by the U.S. Food and Drug Administration for use in people with cancer or who've had organ transplants.
The study of rare diseases can lead to new treatments for common diseases, says a commentary published today in the Journal of the American Medical Association. Its authors are two UW Medicine physicians.
An analysis of tissue samples from 107 human brains has revealed details that will advance medical understanding of the biological bases for Alzheimer’s disease and dementia in older populations.
Dr. Eric B. Larson, 70, knows about aging well. He rides his bike to work (16 miles round-trip). He plays piano and belongs to a book club.
Researchers studying the biology of aging (geroscience) briefly treated middle-age mice with the drug rapamycin to gauge the long-term effects of short-term therapy on health and longevity.
Researchers studying the science of aging cringe at the terms 'anti-aging' and 'Fountain of Youth'.
KING 5 News reports on a program at Gaffney House in Seattle, where residents with Alzheimer's or other forms of dementia listen to personalized playlists of their favorite music from the past.
A collaboration of the Allen Institute for Brain Science, UW Medicine and Group Health has expanded online resources on aging, dementia and traumatic brain injury (TBI).
Could older adults experience measurable health benefits from a group rendition of “Oh, What a Beautiful Morning”?